Andrew Christiansen Cardlytics, Inc. (CDLX) insider trading activity

Andrew Christiansen is Chief Financial Officer of Cardlytics, Inc.. Currently has a direct ownership of 70,775 shares of CDLX, which is worth approximately $274,607. The most recent transaction as insider was on Jul 19, 2023, when has been sold 13,404 shares (Common Stock) at a price of $10.2 per share, resulting in proceeds of $136,720. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70.8K

0% 3M change

0% 12M change

Total Value Held $274,607

Andrew Christiansen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 19 2023	SELL Open market or private sale	$136,720 $10.2 p/Share	13,404 Reduced 15.92%	70,775 Common Stock
Jul 18 2023	BUY Exercise of conversion of derivative security	-	30,147 Added 26.37%	84,179 Common Stock
Jun 23 2023	SELL Open market or private sale	$3,686 $5.68 p/Share	649 Reduced 1.19%	54,032 Common Stock
Jun 22 2023	BUY Exercise of conversion of derivative security	-	2,034 Added 3.59%	54,681 Common Stock
Apr 05 2023	BUY Exercise of conversion of derivative security	-	3,409 Added 6.08%	52,647 Common Stock
Apr 01 2023	BUY Exercise of conversion of derivative security	-	9,677 Added 16.43%	49,238 Common Stock
Mar 22 2023	BUY Exercise of conversion of derivative security	-	8,136 Added 17.06%	39,561 Common Stock
Jan 12 2023	BUY Exercise of conversion of derivative security	-	8,137 Added 20.57%	31,425 Common Stock
Dec 09 2022	BUY Exercise of conversion of derivative security	-	1,875 Added 7.45%	23,288 Common Stock
Nov 08 2022	SELL Open market or private sale	$272 $4.0 p/Share	68 Reduced 0.32%	21,413 Common Stock
Nov 07 2022	SELL Open market or private sale	$5,330 $4.32 p/Share	1,234 Reduced 5.43%	21,481 Common Stock
Oct 06 2022	BUY Exercise of conversion of derivative security	-	1,875 Added 7.63%	22,715 Common Stock
Aug 05 2022	SELL Open market or private sale	$8,776 $14.9 p/Share	589 Reduced 2.75%	20,840 Common Stock
Jun 09 2022	BUY Exercise of conversion of derivative security	-	1,875 Added 8.15%	21,138 Common Stock
May 10 2022	SELL Open market or private sale	$7,300 $29.2 p/Share	250 Reduced 1.28%	19,263 Common Stock
May 05 2022	SELL Open market or private sale	$320,515 $34.39 p/Share	9,320 Reduced 32.32%	19,513 Common Stock
Apr 11 2022	SELL Open market or private sale	$11,688 $46.75 p/Share	250 Reduced 0.86%	28,833 Common Stock
Apr 06 2022	BUY Exercise of conversion of derivative security	-	1,875 Added 6.06%	29,083 Common Stock
Apr 05 2022	BUY Exercise of conversion of derivative security	-	3,408 Added 11.13%	27,208 Common Stock
Apr 01 2022	BUY Exercise of conversion of derivative security	-	9,678 Added 28.91%	23,800 Common Stock
Mar 24 2022	BUY Grant, award, or other acquisition	-	2,017 Added 12.5%	14,122 Common Stock
Mar 10 2022	SELL Open market or private sale	$13,243 $52.97 p/Share	250 Reduced 2.02%	12,105 Common Stock
Feb 10 2022	SELL Open market or private sale	$17,500 $70.0 p/Share	250 Reduced 1.98%	12,355 Common Stock
Jan 10 2022	SELL Open market or private sale	$15,255 $61.02 p/Share	250 Reduced 1.94%	12,605 Common Stock
Dec 10 2021	SELL Open market or private sale	$137,917 $69.34 p/Share	1,989 Reduced 13.4%	12,855 Common Stock

Andrew Christiansen

Chief Financial Officer

Atlanta, GA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDLX shares.

Notify only if

Value

Insider Trading

Get notified when an Cardlytics, Inc. insider buys or sells CDLX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cardlytics, Inc.

Track Activities on CDLX

Account